https://scholars.lib.ntu.edu.tw/handle/123456789/636690
標題: | Consensus recommendations for the treatment and management of patients with Fabry disease on migalastat: a modified Delphi study | 作者: | Bichet, Daniel G Hopkin, Robert J Aguiar, Patrício Allam, Sridhar R YIN-HSIU CHIEN Giugliani, Roberto Kallish, Staci Kineen, Sabina Lidove, Olivier Niu, Dau-Ming Olivotto, Iacopo Politei, Juan Rakoski, Paul Torra, Roser Tøndel, Camilla Hughes, Derralynn A |
關鍵字: | alpha-galactosidase A; amenability; chaperone therapy; globotriaosylsphingosine; patient journey; treatment decisions | 公開日期: | 2023 | 卷: | 10 | 來源出版物: | Frontiers in medicine | 摘要: | Fabry disease is a progressive disorder caused by deficiency of the α-galactosidase A enzyme (α-Gal A), leading to multisystemic organ damage with heterogenous clinical presentation. The addition of the oral chaperone therapy migalastat to the available treatment options for Fabry disease is not yet universally reflected in all treatment guidelines. These consensus recommendations are intended to provide guidance for the treatment and monitoring of patients with Fabry disease receiving migalastat. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/636690 | ISSN: | 2296-858X | DOI: | 10.3389/fmed.2023.1220637 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。